<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02766881</url>
  </required_header>
  <id_info>
    <org_study_id>OCOG-2016-DUCHESS</org_study_id>
    <nct_id>NCT02766881</nct_id>
  </id_info>
  <brief_title>Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS</brief_title>
  <acronym>DUCHESS</acronym>
  <official_title>Evaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ontario Clinical Oncology Group (OCOG)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ontario Clinical Oncology Group (OCOG)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate whether the use of the Oncotype DX DCIS score can guide delivery of radiation in
      women with low to moderate risk DCIS who have had breast conserving surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective cohort study, conducted in Canada, to evaluate whether the use of the DCIS
      score changes the treatment recommended and the treatment received in women with low to
      moderate risk DCIS following breast conserving surgery who are candidates for radiation
      therapy. We plan to study 200 eligible, consenting women who will have their tumour tissue
      specimen sent to Genomic Health to assess their DCIS score.

      At each centre, all patients with DCIS referred to radiation oncology will be documented.
      When a physician identifies an eligible patient, the patient will be approached by the
      referring physician or delegate to voluntarily provide informed consent to participate in
      this study. Consenting patients will be registered through the Ontario Clinical Oncology
      Group's (OCOG) web-based registration system. Data related to the patient demographics,
      surgery details, and tumour characteristics will be collected. The preliminary treatment
      recommendation and patient preference for treatment will be documented. Patient Decisional
      Conflict will be documented by the patient using the Decisional Conflict Scale (DCS). The
      patient's tumour specimen will be sent for analysis to Genomic Health. DCIS score results
      will be sent to the referring physician. OCOG will also receive the DCIS score results. The
      final treatment recommendation, patient preference, and treatment received by the patient
      will be documented. Patient decisional conflict will be documented by the patient using the
      DCS. The study data will be verified by source documentation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in radiotherapy treatment recommendation made by physician</measure>
    <time_frame>2 years</time_frame>
    <description>The primary outcome is change in treatment recommendation by the radiation oncologist. Physicians will be asked to indicate their preliminary treatment recommendation at the first visit based on clinical factors alone. They will be asked to describe course of radiation including dose and number of fractions. They will then be asked to make a final treatment recommendation when the DCIS score is available. If the physician final recommendation is not consistent with the DCIS score predicted treatment, they will be asked to indicate reasons for their recommendation. If radiation is recommended, they will be asked to indicate the treatment prescription including dose and number of fractions. The actual treatment received by the patient will also be collected.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in radiotherapy treatment preference by patient</measure>
    <time_frame>2 years</time_frame>
    <description>Secondary outcomes will include change in treatment preference by the patient for radiotherapy and change in recommendations by the physician for hormonal therapy or further surgery. It will also compare physician's prediction of LR with or without radiation that is estimated by the DCIS score. Finally, change in level of patient decisional conflict as measured by DCS will also be collected. The DCS was developed and used to evaluate the effect of decision aids on decision making by health consumers.The assumption was that decision aids would reduce the uncertainty and confusion in choosing a course of action. Decisional conflict is a state of uncertainty about the course of action to take.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>DCIS</condition>
  <arm_group>
    <arm_group_label>Patients with DCIS</arm_group_label>
    <description>Whether patients with DCIS receive radiotherapy based on Oncotype DX DCIS score, radiation oncologist treatment recommendation and patient's decision.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      patient's tumour sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective cohort study conducted in Ontario in women with a low to moderate risk DCIS
        following breast conserving surgery who are candidates for radiation. Eligibility status
        should be confirmed by the referring physician or delegate prior to enrollment. It is
        important that no exceptions are made to the eligibility criteria. Questions related to
        eligibility requirements and/or specific criteria should be addressed with OCOG prior to
        enrollment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (1) Women with newly diagnosed breast cancer treated by definitive surgery with
        histological evidence limited to DCIS.

        Exclusion Criteria:

          1. Age &lt; or = 45;

          2. Treated by mastectomy;

          3. Surgical margins of &lt;1mm;(re-excisions may be performed where results are regarded as
             clear margins, these cases will not exclude patients);

          4. Tumour size &gt;2.5cm;

          5. Any invasive breast cancer including micro invasion;

          6. Histological evidence of multifocality (defined as having more than one distinct focus
             of DCIS with &gt;5mm of intervening benign breast tissue in one quadrant of the breast);

          7. Any associated lobular carcinoma in situ;

          8. Previous diagnosis of ipsilateral invasive carcinoma or DCIS of the breast;

          9. Any contraindication for whole breast irradiation such as chronic heart or lung
             disease or previous ipsilateral chest wall radiotherapy;

         10. Physician/patient unwilling to comply with study protocol; and

         11. Inability to provide informed consent (e.g. dementia or severe cognitive impairment).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>46 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eileen Rakovitch, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Odette Cancer Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tim Whelan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Juravinski Cancer Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luciana Spadafora</last_name>
    <phone>905-527-2299</phone>
    <phone_ext>42655</phone_ext>
    <email>spadafl@mcmaster.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sharon Nason</last_name>
    <phone>905-527-2299</phone>
    <phone_ext>42622</phone_ext>
    <email>nasons@mcmaster.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Cao, M.D.</last_name>
      <phone>403-521-3077</phone>
      <email>jeffrey.Cao@albertahealthservices.ca</email>
    </contact>
    <contact_backup>
      <last_name>Eva Gyonyor</last_name>
      <phone>403-521-3077</phone>
      <email>eva.gyonyor@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Cao, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivo Olivotto, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petra Grendarova, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Cancer Agency - Vancouver Island</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R6V5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sally Smith, M.D.</last_name>
      <phone>250-519-5576</phone>
      <email>ssmith11@bccancer.bc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Senz Hamilton, R.N.</last_name>
      <phone>250-519-5741</phone>
      <email>senz.hamilton@bccancer.bc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Sally Smith, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanya Berrang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline Truong, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Regional Health Centre</name>
      <address>
        <city>Barrie</city>
        <state>Ontario</state>
        <zip>L4M 6M2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiaan Stevens, M.D.</last_name>
      <phone>705-728-9090</phone>
      <email>stevensc@rvh.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Christine DiMarco</last_name>
      <phone>705-728-9090</phone>
      <phone_ext>43586</phone_ext>
      <email>dimarcoc@rvh.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Christiaan Stevens, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Follwell, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juravinski Cancer Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 5C2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Arsenault, M.D.</last_name>
      <phone>905-387-9711</phone>
      <phone_ext>64704</phone_ext>
      <email>arsenauju@hhsc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Lynn Kelleher, R.N.</last_name>
      <phone>905-387-9711</phone>
      <phone_ext>64430</phone_ext>
      <email>lkellehe@hhsc.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cancer Centre of Southeastern Ontario at Kingston</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 5P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Conrad Falkson</last_name>
      <phone>613-519-6666</phone>
      <phone_ext>4509</phone_ext>
      <email>conrad.falkson@krcc.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Carrie Lindsay</last_name>
      <phone>613-519-6666</phone>
      <phone_ext>6654</phone_ext>
      <email>conrad.falkson@krcc.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Conrad Falkson, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Regional Cancer Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Perera, M.D.</last_name>
      <phone>519-685-8650</phone>
      <email>francisco.perera@lhsc.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Lorraine Hewett</last_name>
      <phone>519-685-8618</phone>
      <email>Lorraine.Hewett@lhsc.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Francisco Perera, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Cao, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Lock, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nancy Read, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tracy Sexton, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Yaremko, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edward Yu, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queensway Health Centre</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Credit Valley Hospital</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M2N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Senti Senthelal, M.D.</last_name>
      <phone>905-813-1100</phone>
      <phone_ext>5115</phone_ext>
      <email>senti.senthelal@thp.ca</email>
    </contact>
    <contact_backup>
      <last_name>Helena Wong</last_name>
      <phone>905-813-1100</phone>
      <phone_ext>4759</phone_ext>
      <email>helena.wong@thp.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Senti Senthelal, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marisa Finlay, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jidong Lian, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Radwan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah Rauth, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johnathan Tsao, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan Wan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yongjin Wang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jasper Yuen, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ottawa Regional Cancer Centre</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laval Grimard, M.D.</last_name>
      <phone>613-737-7700</phone>
      <phone_ext>70196</phone_ext>
      <email>lgrimard@ottawahospital.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Diane Lister</last_name>
      <phone>613-737-7700</phone>
      <phone_ext>70305</phone_ext>
      <email>dilister@toh.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Laval Grimard, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caudrelier Jean-Michel, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Cross, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samy El-Sayed, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine Lochrin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krystine Lupe, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joanne Meng, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Morgan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northeastern Cancer Centre;Health Sciences North</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E 5J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Bowen, M.D</last_name>
      <phone>705-522-6237</phone>
      <phone_ext>4450</phone_ext>
      <email>jbowen@hsnsudbury.ca</email>
    </contact>
    <contact_backup>
      <last_name>Andrea Morrison, R.N.</last_name>
      <phone>705-522-6237</phone>
      <phone_ext>2405</phone_ext>
      <email>amorrison@hsnsudbury.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Ryan Carlson, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Bowen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Pearce, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarwat Shehata, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Want, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thunder Bay Regional Health Sciences Centre</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7B 6V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Anthes, M.D.</last_name>
      <phone>807-684-7566</phone>
      <email>anthesm@tbh.net</email>
    </contact>
    <contact_backup>
      <last_name>Lori Moon</last_name>
      <phone>807-684-7226</phone>
      <email>moonl@tbh.net</email>
    </contact_backup>
    <investigator>
      <last_name>Margaret Anthes, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrien Chan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Odette Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen Rakovitch, M.D.</last_name>
      <phone>416-480-4974</phone>
      <email>eileen.rakovitch@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Eileen Rakovitch, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ida Ackerman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Czarnota, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mary Doherty, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irene Karam, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Justin Lee, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Leung, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hany Soliman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ewa Szumacher, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danny Vespirini, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Koch, M.D.</last_name>
      <phone>416-946-2125</phone>
      <email>anne.koch@rmp.uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Daniel Ang</last_name>
      <phone>416-946-4501</phone>
      <phone_ext>5573</phone_ext>
      <email>daniel.ang@uhn.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Anne Koch, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Fyles, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fei-Fei Liu, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Croke, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tatiana Conrad, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wilfred Levin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kathy Han, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aisling Barry, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joelle Helou, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.ocog.ca</url>
    <description>OCOG website accessed by clinical centres</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2016</study_first_submitted>
  <study_first_submitted_qc>May 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2016</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ductal Carcinoma in Situ</keyword>
  <keyword>DSC</keyword>
  <keyword>Breast Conserving Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Carcinoma, Intraductal, Noninfiltrating</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Genomic Health will provide results to referring physician, OCOG will have access to results</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

